BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7700893)

  • 1. A direct and effective immunomagnetic method for bone marrow purging in non-T ALL malignancies. The use of an anti-HLA-DR antibody gives sustained engraftment.
    Wang MY; Fodstad O; Funderud S; Bengtsson M; Totterman T; Ludwig WD; Martin H; Kvalheim G
    Prog Clin Biol Res; 1994; 389():119-24. PubMed ID: 7700893
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles.
    Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR
    Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts.
    Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
    Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomagnetic purging in autologous bone marrow transplantation: experience in fourteen patients.
    Canals C; Puntí C; Picón M; Amill B; Tugues D; Sanchez T; Badell I; Pardo N; Ortega J; Vivancos P
    Prog Clin Biol Res; 1992; 377():289-96. PubMed ID: 1438427
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
    Skala JP; Rogers PC; Chan KW; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
    [No Abstract]   [Full Text] [Related]  

  • 8. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
    Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
    Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An effective immunomagnetic method for bone marrow purging in T cell malignancies.
    Wang MY; Kvalheim G; Kvaløy S; Beiske K; Jakobsen E; Wijdenes J; Pihl A; Fodstad O
    Bone Marrow Transplant; 1992 May; 9(5):319-23. PubMed ID: 1617315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
    Skala JP; Rogers PC; Chan KW; Khangura SS; Rodriguez WC
    Prog Clin Biol Res; 1992; 377():63-9. PubMed ID: 1438445
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunomagnetic bone marrow purging in children with acute lymphoblastic leukemia.
    Canals C; Torrico C; Picón M; Amill B; Cancelas JA; Fraga G; Badell I; Cubells J; Olivé T; Ortega J; Vivancos P; García J
    J Hematother; 1997 Jun; 6(3):261-8. PubMed ID: 9234181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion.
    Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S
    Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model system for the enrichment of tumor cells from peripheral blood and bone marrow using immunomagnetic ferrofluids.
    Kemshead JT; Hancock JP; Liberti PA
    Prog Clin Biol Res; 1994; 389():593-600. PubMed ID: 7700925
    [No Abstract]   [Full Text] [Related]  

  • 14. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
    Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
    Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy and verapamil to purge drug resistant leukemia cells from human bone marrow.
    Cairo MS; Toy C; Sender L; Bennetts G; van de Ven C
    Prog Clin Biol Res; 1990; 333():47-55. PubMed ID: 2308995
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
    Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
    Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomagnetic manipulation of bone marrow and tumour cells: an update.
    Kemshead JT; Elsom G; Patel K
    Prog Clin Biol Res; 1990; 333():235-50; discussion 251. PubMed ID: 2408061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purging of acute lymphoblastic leukemia by long-term marrow culture.
    Douay L; Ozsahin H; Barbu V; Fabrega S; Giarratana MC; Da WM; Allieri A; Gorin NC
    Prog Clin Biol Res; 1992; 377():205-13; discussion 214. PubMed ID: 1438417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute lymphoblastic leukemia in childhood treated with non-T-cell depleted bone marrow transplantation from an HLA 2 loci (HLA-A and-DRB1)-mismatched mother after early graft failure of cord blood transplantation].
    Ishida H; Mori K; Yoshihara T; Shin N; Morimoto A; Imashuku S
    Rinsho Ketsueki; 2003 Nov; 44(11):1101-6. PubMed ID: 14689875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.